BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Journal

publication venue for

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis 2020
Ruxolitinib Is a Safe and Effective Therapeutic Option for Management of Chronic Gvhd - a Single Center Experience 2020
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement. 25:1890-1897. 2019
Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation. 25:1320-1324. 2019
Higher Risks of Toxicity and Incomplete Recovery in 13-to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. 25:955-964. 2019
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. 25:699-711. 2019
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in the First Prospective Multicenter Trial for Pediatric, Adolescent, and Young Adult Patients with High Risk Acute Leukemias and Myelodysplastic Syndrome 2019
Reduced Intensity Vs Myeloablative Conditioning Regimen for Pediatric Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia 2019
Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease. 24:2233-2238. 2018
Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma with P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy 2018
Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe 2018
Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and is Associated with Decrease Risks of Severe Acute and Chronic Gvhd 2018
Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia 2018
Use of Nitazoxanide, an Anti-Parasitic Drug, for Management of Norovirus Ileo-Colitis in an Allogeneic Stem Cell Transplant Patient 2018
Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience. 23:1722-1728. 2017
Nivolumab is Effective in Relapsed Refractory Hodgkins Lymphoma Patient Following Mismatched Allogeneic Stem Cell Transplantation 2017
Sternal Soft Tissue Mass as Initial Presentation in a Case of Acute Promyelocytic Leukemia (APL) 2017
Transverse Myelitis As a Manifestation of Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation 2017
Low Dose Steroids Can Improve High Grade Febrile Episodes Associated with Blinatumomab Therapy and Limit Treatment Interruptions without Affecting Anti Leukemic Effects 2016
Steroid Refractory Acute Liver GVHD in a Hodgkin's Patient after Allogeneic Stem Transplant Cell Transplantation Following Treatment with Anti PD-1 Antibody, Nivolumab, for Relapsed Disease 2016
Thymoglobulin after Matched Unrelated Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS Results in Improved Outcomes Comparable to Matched Related HCT 2016
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. 21:1776-1782. 2015
Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach. 21:632-639. 2015
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2 2015
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30 2015
Effect of Mobilization Method on Immune Reconstitution Post High Dose Chemotherapy and Autologous Stem Cell Transplantation 2014
Guilain-Barre' Syndrome (GBS) Post Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia (CLL) 2014
Improving Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Scores in Bone Marrow Transplant Inpatient Setting 2014
Low Dose Thymoglobulin Result in Improved Outcomes after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome Conditioned with Intravenous Busulfan and Fludarabine 2014
Performance Validation of Revolution Centrifugal Force (RCF) for Plasma Depletion on Hematopoietic Progenitor Cell Apheresis Product Using Sorvall ST40R Centrifuge 2014
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan Plus Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein-1 2014
Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis-Results of a Crossover Randomized Study. 17:1775-1782. 2011
EVALUATION OF HLA MATCHING REQUIREMENTS IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONMALIGNANT DISORDERS 2011
Spiritual Absence and 1-Year Mortality after Hematopoietic Stem Cell Transplant. 16:1171-1179. 2010
High-Dose Chemotherapy with Blood or Bone Marrow Transplants for Rhabdomyosarcoma. 16:525-532. 2010
LONG TERM SURVIVAL FOLLOWING HIGH DOSE SEQUENTIAL CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC CELL RESCUE FOR MULTIPLE MYELOMA 2010
Preparing for the unthinkable: Emergency preparedness for the hematopoietic cell transplant program. 12:1229-1238. 2006

category

HEMATOLOGY Web of Science Category
IMMUNOLOGY Web of Science Category
TRANSPLANTATION Web of Science Category

International Standard Serial Number (ISSN)

1083-8791

Electronic International Standard Serial Number (EISSN)

1523-6536

journal abbreviation

BIOL BLOOD MARROW TR